Biotage AB (publ) BITGF Stock
Biotage AB (publ) Price Chart
Biotage AB (publ) BITGF Financial and Trading Overview
| Biotage AB (publ) stock price | 15.01 USD |
| Previous Close | 12 USD |
| Open | 12 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 12 - 12 USD |
| 52 Week Range | 12 - 21 USD |
| Volume | 1 USD |
| Avg. Volume | 5 USD |
| Market Cap | 960.38M USD |
| Beta (5Y Monthly) | 0.724521 |
| PE Ratio (TTM) | 36.363636 |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | 0.16 (1.29%) |
| Ex-Dividend Date | April 28, 2023 |
| 1y Target Est | N/A |
BITGF Valuation Measures
| Enterprise Value | 791.81M USD |
| Trailing P/E | 36.363636 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Biotage AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.724521 |
| 52-Week Change | -29.41% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 21 USD |
| 52 Week Low | 12 USD |
| 50-Day Moving Average | 12 USD |
| 200-Day Moving Average | 14.7 USD |
BITGF Share Statistics
| Avg. Volume (3 month) | 5 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 66.71M |
| Float | 65.67M |
| Short Ratio | N/A |
| % Held by Insiders | 0.58% |
| % Held by Institutions | 64.88% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.4294 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 15.57% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 60.15% |
| EBITDA Margin | 21.48% |
Management Effectiveness
| Return on Assets (ttm) | 7.92% |
| Return on Equity (ttm) | 15.27% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -6.50% |
| Gross Profit (ttm) | 948M USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0.33 |
| Quarterly Earnings Growth (yoy) | -39.39% |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 13.63 USD |
| Current Ratio (mrq) | 2.743 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Biotage AB (publ)
| Country | United States |
| State | N/A |
| City | Uppsala |
| Address | Box 8 |
| ZIP | 751 03 |
| Phone | 46 18 56 59 00 |
| Website | https://www.biotage.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 516 |
Biotage AB (publ) provides solution and product in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation product; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, academic, environmental protection, food safety, and agriculture, as well as clinical, forensic, and academic laboratories. It operates in 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.
Q&A For Biotage AB (publ) Stock
What is a current BITGF stock price?
Biotage AB (publ) BITGF stock price today per share is 15.01 USD.
How to purchase Biotage AB (publ) stock?
You can buy BITGF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biotage AB (publ)?
The stock symbol or ticker of Biotage AB (publ) is BITGF.
Which industry does the Biotage AB (publ) company belong to?
The Biotage AB (publ) industry is Medical Instruments & Supplies.
How many shares does Biotage AB (publ) have in circulation?
The max supply of Biotage AB (publ) shares is 80.05M.
What is Biotage AB (publ) Price to Earnings Ratio (PE Ratio)?
Biotage AB (publ) PE Ratio is 0.00000000 now.
What was Biotage AB (publ) earnings per share over the trailing 12 months (TTM)?
Biotage AB (publ) EPS is 0 USD over the trailing 12 months.
Which sector does the Biotage AB (publ) company belong to?
The Biotage AB (publ) sector is Healthcare.


